Piritramide

Piritramide is an opioid analgesic drug that has been studied in several clinical trials for managing postoperative pain and other types of pain. This article summarizes key findings from clinical trials investigating the use of piritramide for pain relief in various surgical and medical contexts.

Table of Contents

What is Piritramide?

Piritramide is a strong pain-relieving medication that belongs to the opioid class of drugs. It is also known by the brand name Dipidolor[5]. Piritramide is primarily used for managing moderate to severe pain, especially in post-surgical settings. As an opioid, it works by binding to specific receptors in the brain and nervous system to reduce pain perception[1].

Uses of Piritramide

Piritramide is commonly used in various medical scenarios, including:

  • Post-operative pain management: It is frequently used to control pain after surgeries such as:
    • Colorectal cancer surgery[3]
    • Minimally invasive aortic valve surgery[2]
    • Shoulder surgery[4]
    • Cesarean section[6]
    • Breast surgery[8]
  • Pain relief during medical procedures: It can be used to reduce pain and anxiety during procedures like bone marrow puncture[7]

Administration Methods

Piritramide can be administered in several ways, depending on the medical situation and patient needs:

  • Intravenous (IV) injection: Directly into a vein, often used in hospital settings[3]
  • Patient-Controlled Analgesia (PCA): A method where patients can self-administer small doses of the medication as needed, using a special pump[2]
  • Subcutaneous (SC) injection: Injected just under the skin[2]

Comparison with Other Pain Medications

Several studies have compared piritramide to other pain medications:

  • Morphine: Some research suggests that piritramide may have advantages over morphine in terms of side effects and effectiveness in certain situations[1][3]
  • Epidural analgesia: In some cases, piritramide is compared to or used alongside epidural analgesia, which involves injecting pain medication near the spinal cord[9]
  • Oxycodone: Studies have compared oral oxycodone to intravenous piritramide for pain management after cesarean sections[6]

Side Effects and Considerations

As with all opioid medications, piritramide can have side effects and risks that patients should be aware of:

  • Nausea and vomiting: Common side effects that may occur after administration[8]
  • Constipation: Opioids can slow down bowel movements[5]
  • Respiratory depression: Like all opioids, piritramide can slow breathing, which requires careful monitoring[5]
  • Risk of addiction: As an opioid, there is a potential for dependence with long-term use[5]

Ongoing Research

Piritramide is the subject of ongoing research to better understand its effects and potential applications:

  • Impact on cancer outcomes: Studies are investigating how different pain management strategies, including piritramide, might affect the spread of cancer cells after surgery[3][9]
  • Comparison with regional anesthesia techniques: Researchers are comparing piritramide-based analgesia to regional anesthesia techniques like nerve blocks for various surgeries[8]
  • Optimal dosing and administration: Studies aim to determine the most effective ways to use piritramide for pain management in different surgical scenarios[2][4]
Aspect Details
Primary Uses Postoperative pain management after various surgeries (colorectal, cardiac, breast, shoulder)
Administration Methods Intravenous, often via patient-controlled analgesia (PCA) devices
Comparisons Often compared to morphine, hydromorphone, and other opioids for efficacy and side effects
Unique Applications Studied for impact on circulating tumor cells in cancer surgeries, pain relief during bone marrow punctures
Side Effects Studied Nausea, vomiting, constipation, respiratory effects, sedation levels
Outcome Measures Pain scores, opioid consumption, patient satisfaction, time to mobilization, hospital length of stay

Ongoing Clinical Trials on Piritramide

  • Study on Ropivacaine and Lidocaine for Reducing Pain After Tonsil Removal in Patients with Chronic Tonsillitis

    Recruiting

    1 1 1 1
    Austria
  • Study on Pain Relief Using Levobupivacaine, Sodium Chloride, and Piritramide for Patients Undergoing Minimally Invasive Aortic Valve Replacement

    Recruiting

    1 1 1
    Belgium

Glossary

  • Piritramide: An opioid analgesic medication used for moderate to severe pain relief, often administered intravenously after surgery.
  • Patient-Controlled Analgesia (PCA): A method of pain control that allows patients to self-administer small doses of pain medication, usually through an intravenous line, as needed.
  • Circulating Tumor Cells: Cancer cells that have detached from a tumor and are found in the bloodstream, potentially leading to the spread of cancer to other parts of the body.
  • Minimally Invasive Surgery: Surgical techniques that use small incisions and specialized instruments to minimize tissue damage and promote faster recovery.
  • Epidural Analgesia: A type of regional anesthesia that involves injecting pain medication into the space around the spinal cord to numb a large area of the body.
  • Numerical Rating Scale (NRS): A pain assessment tool where patients rate their pain intensity on a scale from 0 (no pain) to 10 (worst pain imaginable).
  • Postoperative Nausea and Vomiting (PONV): Common side effects after surgery and anesthesia, often evaluated in pain management studies.
  • Serratus Anterior Plane (SAP) Block: A regional anesthesia technique that involves injecting local anesthetic between chest wall muscles to provide pain relief for certain thoracic surgeries.

References

  1. https://clinicaltrials.gov/study/NCT02314871
  2. https://clinicaltrials.gov/study/NCT03079830
  3. https://clinicaltrials.gov/study/NCT03700541
  4. https://clinicaltrials.gov/study/NCT03541759
  5. https://clinicaltrials.gov/study/NCT04699422
  6. https://clinicaltrials.gov/study/NCT01115101
  7. https://clinicaltrials.gov/study/NCT00188227
  8. https://clinicaltrials.gov/study/NCT02544282
  9. https://clinicaltrials.gov/study/NCT03700411